Henderson et al.,(4646. Henderson VP, Massion AO, Clemow L, Hurley TG, Druker S, Hébert JR. A randomized controlled trial of mindfulness-based stress reduction for women with early-stage breast cancer receiving radiotherapy. Integr Cancer Ther. 2013;12(5):404-13.)
|
7/11 |
163 women with stage I or II of breast cancer (20 to 65 years old) |
G1 = UC (n=58) G2 = MBSR (breast cancer) (n=53) G3 = NEP (n=52) Follow-up: 4 months |
Anxiety - SCL-90-R mean (SD) p value Follow-up: 4 months MBSR versus UC = 0.14 (0.05) versus 0.28 (0.05); p≤0.05 Depression - SCL-90-R mean (SD) p value Follow-up: 4 months MBSR versus NEP = 0.31 (0.08) versus 0.58 (0.08); p≤0.05 |
Reich et al.,(4747. Reich RR, Lengacher CA, Kip KE, Shivers SC, Schell MJ, Shelton MM, et al. Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patients. Biol Res Nurs. 2014;16(4):429-37.)
|
6/11 |
41 women with stage 0, I, II, or III of breast cancer (mean, SD) 58.2 (9.5) years old) |
G1 = UC (n=24) + standard clinic visits G2 = MBSR (breast cancer) 6-week program (n=17) |
Fatigue - MADSI mean (SD) p value Baseline to 6 weeks UC = 9.1 (7.1) to 7.3 (6.0) ns MBSR = 8.8 (6.9) to 4.6 (5.3); p≤0.05 Cognitive/psychological - MADSI mean (SD) p value Baseline to 6 weeks UC = 9.1 (8.7) to 7.8 (8.5) ns MBSR = 7.1(10.1) to 4.3 (5.1) ns |
Rahmani et al.,(4848. Rahmani S, Talepasand S, Ghanbary-Motlagh A. Comparison of effectiveness of the metacognition treatment and the mindfulness-based stress reduction treatment on global and specific life quality of women with breast cancer. Iran J Cancer Prev. 2014;7(4):184-96.)
|
7/11 |
36 women with stages I, II, III of BC (38 to 49 years old) |
G1= CG (n=12) G2= GTM (n=12) G1= MBSR (breast cancer) (n=12) Follow-up: 2 months |
Fatigue - EORTC QLQ-C30 mean (SD) p value Baseline to 8 weeks to follow-up CG = 76.85 (5.72) to 71.29 (12.93) to 72.22 (11.11); p≤0.00 GTM = 75.00 (8.37) to 64.81 (7.97) to 76.85 (10.00); p≤0.00 MBSR = 77.77 (4.73) to 37.96 (8.81) to 47.22 (11.72); p≤0.00, baseline to 8 weeks/8 weeks to follow-up
Cognitive/psychological - EORTC QLQ-C30 mean (SD) Baseline to 8 weeks to follow-up CG = 59.72 (8.58) to 59.72 (11.14) to 58.33 (15.07) GTM = 45.83 (10.36) to 61.11 (10.86) to 58.33 (8.71) MBSR = 62.50 (10.35) to 75.00 (11.23) to 72.22 (12.97) |
Lengacher et al.,(4949. Lengacher CA, Shelton MM, Reich RR, Barta MK, Johnson-Mallard V, Moscoso M, S.et al. Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). J Behav Med. 2014;37(2):185-95.)
|
7/11 |
82 women with stages 0, I, II, III of breast cancer (mean 57 years old) |
G1 = UC (n=42) waitlisted Control Group were offered the MBSR (breast cancer) G2 = MBSR (breast cancer) 6-week program (n=40) Follow-up: 2 week |
Depression - mean (SD) Baseline to 6 weeks UC =14.2 (8.5) to 4.0 (1.7) MBSR = 13.3 (12.0) to 7.2 (4.6) Anxiety - mean (SD) Baseline to 6 weeks UC = 40.4 (11.9) to 6.4 (12.1)
MBSR = 35.3 (12.0) to 7.8 (9.8)
|
Eyles et al.,(5050. Eyles C, Leydon GM, Hoffman CJ, Copson ER, Prescott P, Chorozoglou M, et al. Mindfulness for the self-Management of fatigue, anxiety, and depression in women with metastatic breast cancer: a mixed methods feasibility study. Integr Cancer Ther. 2015;14(1):42-56.)
|
6/11 |
19 women with metastatic breast cancer (37 to 65 years old) |
G1 = MBSR = adapted (the class sessions were reduced to 2 hours in length (instead of 2 hours and 30 minutes) except the first and last, which lasted 2 hours and 30 minutes. The day of mindfulness in week 6 was 4 hours and 30 minutes (instead of 6-7 hours), and the mindfulness home practice using CDs of the above-mentioned mindfulness practices was 30 min/day, instead of 45 minutes/day) Follow-up: 24 week |
Fatigue - BFI mean (SD) p value Baseline to 8 weeks = 4.19 (2.32) to 3.86 (2.45) ns 8 weeks to follow-up = 3.86 (2.45) to 3.28 (1.86) ns Baseline to follow-up = 4.19 (2.32) to 3.86 (2.45) ns Depression – HADS mean (SD) p value Baseline to 8 weeks = 5.74 (3.28) to 5.12 (4.46) ns 8 weeks to follow-up = 5.12 (4.46) to 3.79 (3.14) p≤0.04 Baseline to follow-up = 5.74 (3.28) to 3.79 (3.14) p≤0.04 Anxiety – HADS mean (SD) p value Baseline to 8 weeks = 9.42 (3.49) to 6.66 (3.63) 8 weeks to follow-up = 6.66 (3.63) to 5.79 (3.22) Baseline to follow-up = 9.42 (3.49) to 5.79 (3.22) p≤0.00 |
Rahmani et al.,(51) |
7/11 |
24 women with stages I, II, III of BC (30 to 55 years old) |
G1= CG (n=12) G2 = MBSR (breast cancer) + yoga (n=12) Follow-up: 2 months |
Severe fatigue - FSS mean (SD) p value Baseline to 8 weeks to follow-up CG = 5.69 (1.58) to 5.60 (1.45) to 5.52 (3.07) ns MBSR = 5.85 (1.97) to 4.81 (2.60) to 4.95 (2.61); p≤0.00, baseline to 8 weeks/8 weeks to Follow-up
Fatigue - EORTC QLQ-C30 mean (SD) p value Baseline to 8 weeks to follow-up CG = 76.85 (5.72) to 71.29 (12.93) to 72.22 (11.11) ns MBSR = 77.77 (4.73) to 37.96 (8.81) to 47.22 (11.72); p≤0.00, baseline to 8 weeks/8 weeks to follow-up
Cognitive/psychological - EORTC QLQ-C30 mean (SD) Baseline to 8 weeks to follow-up CG = 59.72 (8.58) to 59.72 (11.14) to 61.11 (16.41) ns MBSR = 62.50 (10.35) to 75.00 (11.23) to 72.22 (12.97) |
Sarenmalm et al.,(5252. Sarenmalm EK, Martensson LB, Andersson BA, Karlsson P, Bergh I. Mindfulness and its efficacy for psychological and biological responses in women with breast cancer. Cancer Med. 2017;6(5):1108-22.)
|
7/11 |
166 women diagnosed with cancer at (34 to 80 years old) |
G1 = active control (8 weeks self-instructing MBSR program), n=52 G2=MBSR (8 weeks self-instructing MBSR program + instructor and weekly group sessions), n=62 G3=non MBSR n=52 |
Anxiety - HADS mean (SD) p value MBSR = 6.5 (4.3) to 6.0 (3.9) ns Non MBSR = 4.8 (3.6) to 5.5 (4.1) ns Active control = 5.6 (3.9) to 5.1 (3.9) ns Depression - HADS mean (SD) p value MBSR = 4.3 (3.7) to 3.3 (3.3) p≤0.00 Non MBSR = 3.5 (3.5) to 3.8 (3.8) ns Active control = 3.4 (3.4) to 3.8 (3.8) ns |